Agile Therapeutics Inc (AGRX)
0.37
+0.04
(+10.78%)
USD |
OTCM |
Mar 27, 16:00
Agile Therapeutics Profit Margin (Quarterly): -11.99% for Sept. 30, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
September 30, 2023 | -11.99% |
June 30, 2023 | -69.22% |
March 31, 2023 | -141.4% |
December 31, 2022 | -98.37% |
September 30, 2022 | -197.5% |
June 30, 2022 | -243.1% |
Date | Value |
---|---|
March 31, 2022 | -589.7% |
December 31, 2021 | -1.29K% |
September 30, 2021 | -1.30K% |
June 30, 2021 | -1.49K% |
March 31, 2021 | -14.77K% |
December 31, 2020 | -2.35K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-14.77K%
Minimum
Mar 2021
-11.99%
Maximum
Sep 2023
-1.88K%
Average
-416.4%
Median
Profit Margin (Quarterly) Benchmarks
Spero Therapeutics Inc | 71.27% |
NovaBay Pharmaceuticals Inc | -53.81% |
Palatin Technologies Inc | -385.6% |
iBio Inc | -- |
Theriva Biologics Inc | -- |
Profit Margin (Quarterly) Related Metrics
Return on Assets | -99.69% |
Gross Profit Margin (Quarterly) | 62.82% |
Operating Margin (Quarterly) | -60.04% |
Return on Net Operating Assets | -192.2% |